An open-label trial to assess the safety of regorafenib in Turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)
Author
Coskun, H. S.
Aykan, N. F.
Sevinc, A.
Sanli, U. S.
Kara, I. O.
Dane, F.
Ozgurdal, K.
Yalcin, S.
Benekli, M.
Yucel, I.
Ozkan, M.
Evrensel, T.
Metadata
Show full item recordCollections
- Bildiri [64839]